AFT Pharmaceuticals Limited (NZSE: AFT)
Health Care · Pharmaceuticals · NZ
NZ$4.64
+6.18% today · +59.5% 1Y
AFT Pharmaceuticals Limited (NZSE: AFT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $272.98M and employs 126 people.
Over the last twelve months the share price has gained 59.5%, trading between 2.87 and 4.85.
Tweenvest scores AFT Pharmaceuticals Limited across four factors: quality 76/100, value 46/100, growth 85/100, dividend 13/100. Its strongest factor is growth.
AFT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $272.98M
- Revenue (TTM)
- $145.54M
- P/E
- 33.14
- EPS
- 0.14
- Dividend yield
- 0.54%
- Beta (5Y)
- 0.47
- 52-week high
- NZ$4.85
- 52-week low
- NZ$2.87
- Avg volume (3M)
- —
- Shares outstanding
- 104.87M
- Employees
- 126
- Next earnings
- —
About AFT Pharmaceuticals Limited
AFT Pharmaceuticals, along with its subsidiaries, focuses on the creation and distribution of pharmaceutical products across New Zealand, Australia, Asia, and other global markets. Their extensive product range addresses a variety of health categories, including but not limited to allergy relief, cold and flu remedies, digestive health, eye care, first aid essentials, nail and oral care, pain management, skincare solutions, and nutritional supplements. This company was established in 1997 and its main office is located in Auckland, New Zealand.
- ISIN
- NZAFTE0001S4
- Founded
- 1997
- Listed since
- Dec 21, 2015
- Exchange
- New Zealand Stock Exchange
- Currency
- NZD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Starpharma Holdings LimitedASX: SPL | $282.89M | AU$0.85 | +5.62% |
| Antibiotice S.A.BVB: ATB | $281.52M | RON2.00 | +0.20% |
| Antengene Corporation LimitedSEHK: 6996 | $279.47M | HK$3.19 | -4.06% |
| Elite Pharmaceuticals, Inc.OTCPK: ELTP | $274.78M | $0.26 | -3.74% |
| Pharmasaga Co. Ltd.TPEX: 7878 | $272.92M | NT$163.00 | -2.10% |
| Hikal LimitedBSE: 524735 | $271.94M | Rs213.45 | -2.15% |
| Duopharma Biotech BerhadKLSE: DPHARMA | $266.04M | RM1.13 | -0.88% |
| Fredun Pharmaceuticals LimitedBSE: 539730 | $265.41M | Rs1,553.15 | +14.79% |
Figures last refreshed Oct 11, 2026.